SOD1 and chronic myelogenous leukemia, BCR-ABL1 positive: 8 weeks of supplementation with resistant dextrin (10 g/d) in comparison with placebo in 65 diabetic patients resulted in a significant decrease in CML and 8-iso-PGF2α and a significant increase in TAC and s-RAGE without any effect on SOD, GPX, catalase, pentosidine, and uric acid [44].